News about Global Pharma

Florida-based Formulated Solutions to buy Merck & Co and Bayer manufacturing facility

The manufacturing facility is located in Cleveland, Tennessee

Global Pharma | 21/12/2022 | By Sudeep Soparkar |  1393

JB Pharma to acquire the entire Razel (Rosuvastatin) franchise for Rs. 314 crores

The acquisition marks JB Pharma’s entry into the ‘Statin’ segment which is the largest group in the cardiac therapy. Razel ranks among the top 10 brands in the Rosuvastatin molecule category in the country <br />

Global Pharma | 15/12/2022 | By Sudeep Soparkar |  734

Lupin appoints Spiro Gavaris as President of US generics biz

Gavaris will be responsible for the overall strategy, implementation and growth of Lupin’s US Generics business

Global Pharma | 09/12/2022 | By Sudeep Soparkar |  487

Akums enters into joint association with Leiutis and Biophore for therapeutics

The partnership leverages the strengths of each of the companies resulting in an innovation strategy creating a unique value proposition to doctors and patients in India

Global Pharma | 01/12/2022 | By Sudeep Soparkar |  1533

15th edition of CPHI & PMEC India showcases array of pharma machinery, equipment, ingredients and tech

The event witnessed 50,000 visitors from across the globe, more than 1,500 exhibitors and representation from over 80 countries

Global Pharma | 30/11/2022 | By Sudeep Soparkar |  640

Lupins' Brazilian arm buys nine brand rights from Bausch Health

Medqumica develops an extensive line of both solid and liquid medicines in Brazil

Global Pharma | 29/11/2022 | By Sudeep Soparkar |  1031

Glenmark Pharma in agreement with Pfizer for Axitinib tabs, 1 mg and 5 mg

The Inlyta tablets, 1 mg and 5 mg market 2 achieved annual sales of approximately $644.5 million

Global Pharma | 22/11/2022 | By Sudeep Soparkar |  818

CPhI & P-MEC India expo to encourage cost-effective solutions

The shows will bring together over 1500 exhibitors showcasing 5000+ products across 100,000+ sq m of exhibition space

Global Pharma | 18/11/2022 | By Sudeep Soparkar |  1223

India pharma forecast record growth for 2023 ahead of CPHI & PMEC India

Scoring second only to the US in ‘growth potential’ and ‘overall competitiveness’ in the CPHI Annual Survey

Global Pharma | 16/11/2022 | By Sudeep Soparkar |  1220

Investment firm Bridgewest Group buys Pfizer manufacturing facility in Australia

As part of the deal, Bridgewest also will gain an undisclosed group of drugs from Pfizer

Global Pharma | 15/11/2022 | By Sudeep Soparkar |  1056